Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 5 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Bright Ideas - CIN Feasibility StudyRecruitingNCT04929899Not applicable
- Methods of T Cell Depletion Trial (MoTD)RecruitingNCT04888741Phase 2
- Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ LeukemiaRecruitingNCT04881240Phase 1
- Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALRecruitingNCT04872478Phase 1
- Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaRecruitingNCT04825496Phase 1
- Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOPRecruitingNCT04794296
- Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.RecruitingNCT04771572Phase 1
- Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic LeukemiaRecruitingNCT04767165Not applicable
- Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCTRecruitingNCT04764513Phase 1/2
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)RecruitingNCT04747912Phase 2
- Blinatumomab After TCR Alpha Beta/CD19 Depleted HCTRecruitingNCT04746209Phase 2
- The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyRecruitingNCT04726241Phase 1/2
- Study in Adult Ph-positive ALLNot yet recruitingNCT04688983Phase 2
- Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic LeukemiaRecruitingNCT04684147Phase 2
- CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's LymphomaNot yet recruitingNCT04609241Early Phase 1
- CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological MalignanciesRecruitingNCT04603872Early Phase 1
- A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLNot yet recruitingNCT04595162Phase 1
- Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALLRecruitingNCT04582487Not applicable
- HIIT in Youth With Congenital Heart Disease (MedBIKE)RecruitingNCT04575883Not applicable
- Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）RecruitingNCT04534634Phase 2
- A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignanciesRecruitingNCT04532281Early Phase 1
- A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHLRecruitingNCT04532268Early Phase 1
- A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological MalignanciesRecruitingNCT04532203Early Phase 1
- Impact of a mHealth Supportive Tool on Cardiopulmonary Resuscitation' Situational AwarenessNot yet recruitingNCT04464603Not applicable
- Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia PatientsRecruitingNCT04314219Phase 3
- A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic LeukaemiaRecruitingNCT04307576Phase 3
- Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological MalignanciesRecruitingNCT04290000
- Study of HQP1351 in Subjects With Refractory CML and Ph+ ALLRecruitingNCT04260022Phase 1
- A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological MalignancyRecruitingNCT04227015Early Phase 1
- Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic LeukemiaRecruitingNCT04209244Not applicable
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesRecruitingNCT04195633Phase 2
- Study of CM4620 to Reduce the Severity of Pancreatitis Due to AsparaginaseRecruitingNCT04195347Phase 1/2
- Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in AdultsRecruitingNCT04179929Not applicable
- Study of Out of Specification for TisagenlecleucelRecruitingNCT04094311Phase 3
- A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationRecruitingNCT04065399Phase 1/2
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic LymphomaRecruitingNCT04043494Phase 3
- A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBLRecruitingNCT03971318
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)RecruitingNCT03970096Phase 2
- Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)RecruitingNCT03938987Phase 1/2
- Intravenous Autologous CD19 CAR-T Cells for R/R B-ALLRecruitingNCT03937544Phase 2/3
- Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid TumorsRecruitingNCT03934372Phase 1/2
- Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With LeukemiaRecruitingNCT03932903Not applicable
- A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic LeukaemiaRecruitingNCT03911128
- Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity ConditioningRecruitingNCT03852407Phase 2
- CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCTRecruitingNCT03810196Not applicable
- A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesRecruitingNCT03802695Phase 1
- CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic MalignanciesRecruitingNCT03765177Phase 1/2
- Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CARRecruitingNCT03676504Phase 1/2
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeRecruitingNCT03670966Phase 1/2
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017RecruitingNCT03643276Phase 3
- Pilot Imaging Study of LeukemiaRecruitingNCT03633955Phase 1
- CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.RecruitingNCT03614858Phase 1/2
- International Study for Treatment of High Risk Childhood Relapsed ALL 2010RecruitingNCT03590171Phase 2
- Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic LeukemiaRecruitingNCT03571321Phase 1
- Pharmacogenomics of Asparaginase Induced HepatotoxicityRecruitingNCT03568266
- Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant CyclophosphamideRecruitingNCT03533816Phase 1
- The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLRecruitingNCT03509961Phase 2
- Pharmacokinetics of Drugs Administered to ChildrenRecruitingNCT03481881
- Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALLRecruitingNCT03460522Phase 2
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)RecruitingNCT03390387Not applicable
- HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantRecruitingNCT03326921Phase 1
- Myeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersRecruitingNCT03314974Phase 2
- CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDSRecruitingNCT03291444Phase 1
- Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaRecruitingNCT03263572Phase 2
- Leukapheresis for CAR or Adoptive Cell Therapy ManufacturingEnrolling by invitationNCT03226704
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaRecruitingNCT03136146Phase 2
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaRecruitingNCT03128034Phase 1/2
- Auto Stem Cell Transplant for Lymphoma PatientsRecruitingNCT03125642Phase 2
- Expanded Access to VenetoclaxAvailableNCT03123029
- Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic LeukemiaRecruitingNCT03104491Phase 1/2
- CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic LeukemiaRecruitingNCT03064269Phase 1
- Amish/Mennonite Research Contact RegistryRecruitingNCT02990572
- GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of BiomaterialRecruitingNCT02872987
- Personalized NK Cell Therapy in CBTRecruitingNCT02727803Phase 2
- ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)RecruitingNCT02670564Phase 4
- KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT ChildrenEnrolling by invitationNCT02646839Phase 2
- Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)RecruitingNCT02619630Phase 2
- Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young AdultsRecruitingNCT02617004
- A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young AdultsRecruitingNCT02611492Phase 3
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsRecruitingNCT02508038Phase 1
- CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic LeukaemiaRecruitingNCT02443831Phase 1
- Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic LymphomaRecruitingNCT02396043Phase 2
- Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...RecruitingNCT02390752Phase 1
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaRecruitingNCT01949129Phase 2/3
- The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative RegimenRecruitingNCT01890486
- Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood TransplantsAvailableNCT01881334
- Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)RecruitingNCT01853631Phase 1
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruitingNCT01790152
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)RecruitingNCT01351545
- Registry of Older Patients With CancerRecruitingNCT01137825
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruitingNCT01137643
- Biology Studies of Hematologic CancersEnrolling by invitationNCT00923442
- Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT05968963Not applicableResults posted
- BESPONSA Injection 1 mg Special InvestigationCompletedNCT05923112Results posted
- Insomnia Prevention in Children With Acute Lymphoblastic LeukemiaCompletedNCT05866887Not applicableResults posted
- Positive Youth Development in the MetaverseCompletedNCT05858593Not applicableResults posted
- A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT05687032Phase 4Results posted
- Vaccine Immune Recovery After LeukemiaCompletedNCT05622682Results posted
- A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last TreatmentCompletedNCT05597085Results posted
- Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac ArrestCompletedNCT05474170Not applicableResults posted